S.Pablo Sardi

A novel brain-penetrant oral UGT8 inhibitor decreases in vivo galactosphingolipid biosynthesis in murine Krabbe disease.

R. Barker, S. Sardi, Hyejung Park, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.